Table 3. Frequency of skip metastases according to tumor location in cases with pleural involvement.
| Location | Number | N1 mets in peripheral zone (#12/#13), n [%] | Skip N1 mets in hilar/interlobar zone (#10/#11), n [%] | Skip N2 mets, n [%] | Most frequent station of skip mets | |
|---|---|---|---|---|---|---|
| Station | N [%] | |||||
| Rt. S1 | 11 | 6 [55] | 1 [9] | 4 [36] | #4R | 4 [36] |
| Rt. S2 | 15 | 7 [47] | 5 [33] | 3 [20] | #4R/#10 | 3 [20] |
| Rt. S3 | 8 | 4 [50] | 0 [0] | 4 [50] | #4R | 4 [50] |
| Rt. S4–5 | 13 | 10 [77] | 1 [8] | 2 [15] | #4R | 2 [15] |
| Rt. S6 | 10 | 4 [40] | 5 [50] | 1 [10] | #11i | 3 [30] |
| Rt. S7–8 | 5 | 2 [40] | 3 [60] | 0 [0] | #11s | 2 [40] |
| Rt. S9–10 | 5 | 2 [40] | 2 [40] | 1 [20] | #11i | 2 [40] |
| Lt. S1+2 | 11 | 7 [64] | 1 [9] | 3 [27] | #5 | 2 [18] |
| Lt. S3 | 9 | 6 [66] | 0 [0] | 3 [33] | #5 | 3 [33] |
| Lt. S4–5 | 10 | 6 [60] | 2 [20] | 2 [20] | #11 | 2 [20] |
| Lt. S6 | 9 | 5 [56] | 3 [33] | 1 [11] | #10 | 2 [22] |
| Lt. S8 | 8 | 3 [38] | 3 [38] | 2 [25] | #11 | 2 [25] |
| Lt. S9–10 | 9 | 7 [78] | 1 [11] | 1 [11] | #7/#10 | 1 [11] |
| RUL | 34 | 17 [50] | 6 [18] | 11 [32] | #4R | 11 [32] |
| RLL | 20 | 8 [40] | 10 [50] | 2 [10] | #11i | 6 [30] |
| LUL | 30 | 19 [63] | 3 [10] | 8 [27] | #5 | 5 [17] |
| LLL | 26 | 15 [58] | 7 [27] | 4 [15] | #10 | 4 [15] |
| Total | 123 | 69 [56] | 27 [22] | 27 [22] | – | – |
Skip metastasis was defined as nodal metastasis without metastasis to more peripheral lymph nodes. Mets, metastases; Rt, right; Lt, left; RUL, right upper lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe.